Company / Operating Cash Flow per Share
InMed Pharmaceuticals Inc. Operating Cash Flow per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$15.67
FY2025
5-year range
-$30.40 / -$2.19
FY2022-FY2025
Trend
-615.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -616% YoY in FY2025, a notable deviation from the 3-year average annual change of -168%.
Based on SEC 10-K filings.
-15.67 in FY2025.
Improved from $-23.95 to $-15.67 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 615.9% year-over-year.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$15.67 | -615.9% |
| FY2024 | -$2.19 | +90.9% |
| FY2023 | -$23.95 | +21.2% |
| FY2022 | -$30.40 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026